NSEDisclosure under SEBI Takeover Regulations19 Jun 2026 · 19 Jun 2026, 01:04 pm

Disclosure under SEBI Takeover Regulations

Nephrocare Health Services Limited · NEPHROPLUS

✦ AI Summary

Nephrocare Health Services Limited announced a disclosure from its promoter, Edoras Investment Holdings Pte. Ltd., under SEBI Takeover Regulations 31(4). Edoras Investment Holdings confirmed that no new encumbrances were created on its shares in Nephrocare Health Services during the financial year ended March 31, 2026. This annual declaration assures stakeholders that no additional shares were pledged or used as collateral by the promoter during the period. For investors, this indicates stability in the promoter's shareholding, mitigating concerns about potential selling pressure arising from new pledged shares.

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

 Edoras Investment Holdings Pte. Ltd has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Attachments (1)

📄

team_bbodade_08052026190438_NEPHROPLUS.pdf

pdf

Download →
View document text
EDORAS INVESTMENT HOLDINGS PTE. LTD. (the "Company") (Company Registration No. 202237475G) (Incorporated in the Republic of Singapore) April 7, 2026 To To BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, 5th Floor, Exchange Plaza, Bandra (E), Mumbai – 400 001 Mumbai – 400 051 Scrip Code: 544647 Scrip Symbol: NEPHROPLUS Mail Id: corp.relations@bseindia.com Mail id: takeover@nse.co.in Sub: Annual Declaration under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dear Sir/Ma’am, We, Edoras Investment Holdings Pte. Ltd, being a promoter of Nephrocare Health Services Limited (“Target Company”), together with persons acting in concert, hereby confirm and declare that, in terms of Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, no encumbrance has been created, directly or indirectly, on the shares of the Target Company during the financial year ended March 31, 2026 other than those already disclosed. Please take this disclosure on record and acknowledge receipt. Thanking you. Yours faithfully, For Edoras Investment Holdings Pte. Ltd Authorized Signatory a. The Audit Committee b. The Company Secretary and Compliance Officer Nephrocare Health Services Limited (Formerly Known as Nephrocare Health Services Private Limited) 5th Floor, D Block, ilabs Centre, Plot 18, Software, Units Layout, Survey No. 64, Madhapur, Hyderabad – 500081, Telangana Mail id: cs@nephroplus.com , auditcommittee@nephroplus.com